![Lloyd Sanders](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de Lloyd Sanders
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Epic Sciences, Inc.
![]() Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA. | Director/Miembro de la Junta | 25/03/2019 | - |
Director Ejecutivo | 25/03/2019 | - | |
Presidente | 25/03/2019 | - |
Historial de carrera de Lloyd Sanders
Antiguos cargos conocidos de Lloyd Sanders.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Mylan Specialty LP
![]() Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Mylan Specialty LP develops, manufactures, and markets respiratory disease & allergy treatment products. The company was founded in 1978 and is headquartered in Morgantown, WV. | Director de Operaciones | 06/05/2011 | - |
Estadísticas
Internacional
Estados Unidos | 3 |
Operativa
Chief Operating Officer | 1 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectorial
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Mylan Specialty LP
![]() Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Mylan Specialty LP develops, manufactures, and markets respiratory disease & allergy treatment products. The company was founded in 1978 and is headquartered in Morgantown, WV. | Health Technology |
Epic Sciences, Inc.
![]() Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Lloyd Sanders
- Experiencia